XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ 21,010 $ (25,151)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation, depletion and amortization 128,423 119,605
Amortization of debt issuance costs 2,126 1,952
Impairment of oil and gas properties 43,980 0
Stock-based compensation expense 4,676 11,336
Deferred income taxes 4,850 (10,397)
Other operating expenses (2,135) 1,283
Derivative activities:    
Total losses 16,508 48,901
Cash settlements (paid) received on derivatives (38,606) 15,511
Changes in assets and liabilities:    
Decrease in accounts receivable 12,414 11,644
Decrease (increase) in other assets 7,072 (3,820)
Decrease in accounts payable and accrued expenses (48,819) (53,347)
Increase in other liabilities 17,360 2,122
Net cash provided by operating activities 168,859 119,639
Capital expenditures:    
Capital expenditures (85,135) (56,124)
Changes in capital expenditures accruals 1,219 (10,431)
Acquisitions, net of cash received (9,188) (59,895)
Proceeds from sale of property and equipment and other 7,455 0
Net cash used in investing activities (85,649) (126,450)
Cash flows from financing activities:    
Borrowings under 2021 RBL credit facility 502,500 387,000
Repayments on 2021 RBL credit facility (506,000) (330,000)
Dividends paid on common stock (46,719) (62,274)
Payment of deferred acquisition payable (20,000) 0
Purchase of treasury stock 0 (10,029)
Shares withheld for payment of taxes on equity awards and other (5,257) (6,936)
Debt issuance cost (3,098) 0
Net cash used in financing activities (78,574) (22,239)
Net increase (decrease) in cash and cash equivalents 4,636 (29,050)
Cash and cash equivalents:    
Beginning 4,835 46,250
Ending $ 9,471 $ 17,200